Prothrombin complex concentrate (PCC) is a term to describe pharmacological products that contain lyophilized, human plasma-derived vitamin K-dependent factors (F), FII, FVII, FIX, FX, and various amounts of proteins C and S. PCCs can be rapidly reconstituted in a small volume (20 ml for about 500 international units (IU)) at bedside and administered regardless of the patient's blood type. PCCs are categorized as 4-factor PCC if they contain therapeutic amounts of FVII, and 3-factor PCC when FVII content is low. In addition, activated PCC which contains activated FVII and FX with prothrombin is available for factor VIII bypassing therapy in hemophilia patients with inhibitors. Currently, 4-factor PCC is approved for the management of bleeding in patients taking warfarin, but there has been increasing use of various PCCs in the treatment of acquired perioperative coagulopathy unrelated to warfarin therapy and in the management of bleeding due to novel oral anticoagulants. There is also an ongoing controversy about plasma transfusion and its potential hazards including transfusion-related lung injury (TRALI). Early fixed ratio plasma transfusion has been implemented in many trauma centers in the USA, whereas fibrinogen concentrate and PCC are preferred over plasma transfusion in some European centers. In this review, the rationales for including PCCs in the perioperative hemostatic management will be discussed in conjunction with plasma transfusion.

Department of Anesthesiology and Critical Care Medicine 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Anesthesiology Cardiothoracic Anesthesia Division University of Maryland Suite S8D12 22 South Greene Street Baltimore MD 21201 USA

Zobrazit více v PubMed

Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447–458. PubMed

Inaba K, Lustenberger T, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, Nelson J, Talving P, Demetriades D. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg. 2010;211:573–579. doi: 10.1016/j.jamcollsurg.2010.06.392. PubMed DOI

Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PG, Shulman I, Nelson J, Demetriades D. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg. 2010;210:957–965. doi: 10.1016/j.jamcollsurg.2010.01.031. PubMed DOI

Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma. 2009;67:221–227. doi: 10.1097/TA.0b013e3181ad5957. PubMed DOI

Inaba K, Branco BC, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, Nelson J, Demetriades D. Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg. 2010;145:899–906. doi: 10.1001/archsurg.2010.175. PubMed DOI

Key NS, Negrier C. Coagulation factor concentrates: past, present, and future. Lancet. 2007;370:439–448. doi: 10.1016/S0140-6736(07)61199-4. PubMed DOI

Lin DM, Murphy LS, Tran MH. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev. 2013;27:91–104. doi: 10.1016/j.tmrv.2013.01.002. PubMed DOI

Tanaka KA, Esper S, Bolliger D. Perioperative factor concentrate therapy. Br J Anaesth. 2013;111(Suppl 1):i35–i49. doi: 10.1093/bja/aet380. PubMed DOI

Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791–1800. doi: 10.1056/NEJMoa1006221. PubMed DOI

Sarode R, Milling TJ, Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234–1243. PubMed PMC

Chhibber V, Greene M, Vauthrin M, Bailey J, Weinstein R. Is group A thawed plasma suitable as the first option for emergency release transfusion? Transfusion. 2014;54:1751–1755. doi: 10.1111/trf.12537. PubMed DOI

Mehr CR, Gupta R, von Recklinghausen FM, Szczepiorkowski ZM, Dunbar NM. Balancing risk and benefit: maintenance of a thawed group A plasma inventory for trauma patients requiring massive transfusion. J Trauma Acute Care Surg. 2013;74:1425–1431. doi: 10.1097/TA.0b013e31828b813e. PubMed DOI

Thiele T, Kellner S, Hron G, Wasner C, Nauck M, Zimmermann K, Wessel A, Warkentin TE, Greinacher A, Selleng K. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation. Transfusion. 2012;52:529–536. doi: 10.1111/j.1537-2995.2011.03317.x. PubMed DOI

Downes KA, Wilson E, Yomtovian R, Sarode R. Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion. 2001;41:570. doi: 10.1046/j.1537-2995.2001.41040570.x. PubMed DOI

Tholpady A, Monson J, Radovancevic R, Klein K, Bracey A. Analysis of prolonged storage on coagulation factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days? Transfusion. 2013;53:645–650. doi: 10.1111/j.1537-2995.2012.03786.x. PubMed DOI

Boldt J, Huttner I, Suttner S, Kumle B, Piper SN, Berchthold G. Changes of haemostasis in patients undergoing major abdominal surgery—is there a difference between elderly and younger patients? Br J Anaesth. 2001;87:435–440. doi: 10.1093/bja/87.3.435. PubMed DOI

Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009;49:2652–2660. doi: 10.1111/j.1537-2995.2009.02335.x. PubMed DOI

Cardigan R, Lawrie AS, Mackie IJ, Williamson LM. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. Transfusion. 2005;45:1342–1348. doi: 10.1111/j.1537-2995.2005.00219.x. PubMed DOI

Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology. 2007;1:179–186. doi: 10.1182/asheducation-2007.1.179. PubMed DOI

Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125:69–73. doi: 10.1111/j.1365-2141.2004.04868.x. PubMed DOI

Kor DJ, Stubbs JR, Gajic O. Perioperative coagulation management—fresh frozen plasma. Best Pract Res Clin Anaesthesiol. 2010;24:51–64. doi: 10.1016/j.bpa.2009.09.007. PubMed DOI

Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA, Group TS. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119:1757–1767. doi: 10.1182/blood-2011-08-370932. PubMed DOI PMC

Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008–2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion. 2013;53:1442–1449. doi: 10.1111/j.1537-2995.2012.03935.x. PubMed DOI

Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion. 2009;49:1171–1177. doi: 10.1111/j.1537-2995.2008.02080.x. PubMed DOI

Imberti D, Barillari G, Biasioli C, Bianchi M, Contino L, Duce R, D’Inca M, Gnani MC, Mari E, Ageno W. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus. 2011;9:148–155. PubMed PMC

Joseph B, Hadjizacharia P, Aziz H, Kulvatunyou N, Tang A, Pandit V, Wynne J, O’Keeffe T, Friese RS, Rhee P. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg. 2013;74:248–253. doi: 10.1097/TA.0b013e3182788a40. PubMed DOI

Tanaka KA, Mazzeffi MA, Grube M, Ogawa S, Chen EP. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion. 2013;53:920–921. doi: 10.1111/trf.12110. PubMed DOI

Ogawa S, Szlam F, Ohnishi T, Molinaro RJ, Hosokawa K, Tanaka KA. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost. 2011;106:1215–1223. doi: 10.1160/TH11-04-0240. PubMed DOI

Turecek PL, Varadi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia. 2004;10(Suppl 2):3–9. doi: 10.1111/j.1365-2516.2004.00934.x. PubMed DOI

Wojcik C, Schymik ML, Cure EG. Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy. Int J Emerg Med. 2009;2:217–225. doi: 10.1007/s12245-009-0125-8. PubMed DOI PMC

Reply GA, Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica. 2008;93:e24–e26. doi: 10.3324/haematol.12151. PubMed DOI

Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55. doi: 10.1186/cc8948. PubMed DOI PMC

Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology. 2011;115:1179–1191. PubMed

Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117:531–547. doi: 10.1097/ALN.0b013e318264c644. PubMed DOI

Fassl J, Matt P, Eckstein F, Filipovic M, Gregor M, Zenklusen U, Seeberger MD, Bolliger D. Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management. J Cardiothorac Vasc Anesth. 2013;27:1181–1188. doi: 10.1053/j.jvca.2013.02.009. PubMed DOI

Tanaka KA, Bolliger D, Vadlamudi R, Nimmo A. Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma. J Cardiothorac Vasc Anesth. 2012;26:1083–1093. doi: 10.1053/j.jvca.2012.06.015. PubMed DOI

Girdauskas E, Kempfert J, Kuntze T, Borger MA, Enders J, Fassl J, Falk V, Mohr FW. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg. 2010;140:1117–1124. doi: 10.1016/j.jtcvs.2010.04.043. PubMed DOI

Majeed A, Eelde A, Agren A, Schulman S, Holmstrom M. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res. 2012;129:146–151. doi: 10.1016/j.thromres.2011.07.024. PubMed DOI

Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev. 2013;27:213–220. doi: 10.1016/j.tmrv.2013.08.004. PubMed DOI

Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121:3554–3562. doi: 10.1182/blood-2012-11-468207. PubMed DOI

Lu G, DeGuzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, Luan P, Hutchaleelaha A, Inagaki M, Conley PB, Phillips DR, Sinha U. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med. 2013;19:446–451. doi: 10.1038/nm.3102. PubMed DOI

Cotton BA, McCarthy JJ, Holcomb JB. Acutely injured patients on dabigatran. N Engl J Med. 2011;365:2039–2040. doi: 10.1056/NEJMc1111095. PubMed DOI

Harper P, Young L, Merriman E. Bleeding risk with dabigatran in the frail elderly. N Engl J Med. 2012;366:864–866. doi: 10.1056/NEJMc1112874. PubMed DOI

Garber ST, Sivakumar W, Schmidt RH. Neurosurgical complications of direct thrombin inhibitors—catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. J Neurosurg. 2012;116:1093–1096. doi: 10.3171/2012.2.JNS112132. PubMed DOI

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood. 2012;119:2172–2174. doi: 10.1182/blood-2011-11-393587. PubMed DOI

Tanaka KA, Bolliger D. On the reversal of new oral anti-coagulants: can we simply extrapolate data from the animal models to humans? Br J Anaesth. 2013;110:329–332. doi: 10.1093/bja/aes502. PubMed DOI

Dickneite G, Hoffman M. Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence? Thromb Haemost. 2014;111:189–198. doi: 10.1160/TH13-05-0431. PubMed DOI

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost. 2012;108:217–224. doi: 10.1160/TH12-03-0179. PubMed DOI

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573–1579. doi: 10.1161/CIRCULATIONAHA.111.029017. PubMed DOI

Zhou W, Schwarting S, Illanes S, Liesz A, Middelhoff M, Zorn M, Bendszus M, Heiland S, van Ryn J, Veltkamp R. Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran. Stroke. 2011;42:3594–3599. doi: 10.1161/STROKEAHA.111.624650. PubMed DOI

van Ryn J, Schurer J, Kink-Eiband M, Clemens A. Successful reversal of dabigatran-induced bleeding by 3-factor coagulation concentrates in a rat tail bleeding model: lack of correlation with ex vivo markers of anticoagulation. Circulation. 2012;126

Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, Marchand-Leroux C, Lecompte T, Samama CM. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology. 2012;116:94–102. doi: 10.1097/ALN.0b013e318238c036. PubMed DOI

Perzborn E, Gruber A, Tinel H, Marzec UM, Buetehorn U, Buchmueller A, Heitmeier S, Laux V. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates. Thromb Haemost. 2013;110:162–172. doi: 10.1160/TH12-12-0907. PubMed DOI

Zhou W, Zorn M, Nawroth P, Butehorn U, Perzborn E, Heitmeier S, Veltkamp R. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban. Stroke. 2013;44:771–778. doi: 10.1161/STROKEAHA.112.675231. PubMed DOI

Siegal DM, Garcia DA, Crowther MA. How I treat target-specific oral anticoagulant-associated bleeding. Blood. 2014;123:1152–1158. doi: 10.1182/blood-2013-09-529784. PubMed DOI

Durila M, Malosek M. Rotational thromboelastometry along with thromboelastography plays a critical role in the management of traumatic bleeding. Am J Emerg Med. 2014;32:288. doi: 10.1016/j.ajem.2013.09.038. PubMed DOI

Yasunaga H. Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan. Lancet. 2007;370:2063–2067. doi: 10.1016/S0140-6736(07)61867-4. PubMed DOI

Yamamoto K, Usui A, Takamatsu J. Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair. J Cardiothorac Surg. 2014;9:90. doi: 10.1186/1749-8090-9-90. PubMed DOI PMC

Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology. 2010;113:1205–1219. doi: 10.1097/ALN.0b013e3181f22b5a. PubMed DOI

Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112:1289–1295. doi: 10.1213/ANE.0b013e318210385c. PubMed DOI PMC

Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood. 2011;118:1943–1951. doi: 10.1182/blood-2011-03-343046. PubMed DOI

Mitterlechner T, Innerhofer P, Streif W, Lodl M, Danninger T, Klima G, Hansson K, Fries D. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost. 2011;9:729–737. doi: 10.1111/j.1538-7836.2011.04211.x. PubMed DOI

Hiippala S. Replacement of massive blood loss. Vox Sang. 1998;74(Suppl 2):399–407. doi: 10.1111/j.1423-0410.1998.tb05449.x. PubMed DOI

Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth. 2010;104:318–325. doi: 10.1093/bja/aeq001. PubMed DOI

Sniecinski R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg. 2008;106:713–718. doi: 10.1213/ane.0b013e3181608f7c. PubMed DOI

Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009;108:1433–1446. doi: 10.1213/ane.0b013e31819bcc9c. PubMed DOI

Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev. 2012;26:1–13. doi: 10.1016/j.tmrv.2011.07.005. PubMed DOI

Tanaka KA, Bader SO, Sturgil EL. Diagnosis of perioperative coagulopathy—plasma versus whole blood testing. J Cardiothorac Vasc Anesth. 2013;27:S9–S15. doi: 10.1053/j.jvca.2013.05.012. PubMed DOI

Hanke AA, Joch C, Gorlinger K. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br J Anaesth. 2013;110:764–772. doi: 10.1093/bja/aes501. PubMed DOI PMC

Koster A, Meyer-Jark T, Schirmer U, Sandica E. Fulminant intraoperative right heart and pulmonary artery thrombosis following prothrombin complex concentrate infusion after complex open heart surgery with cardiopulmonary bypass. A&A Case Rep. 2014;2:89–91. doi: 10.1097/ACC.0b013e3182a070e9. PubMed DOI

Sniecinski RM, Chen EP, Tanaka KA. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis. 2008;19:178–179. doi: 10.1097/MBC.0b013e3282f40d4a. PubMed DOI

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Massive hemorrhage management-a best evidence topic report